{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:36:42Z","timestamp":1765280202336,"version":"3.46.0"},"reference-count":40,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2020-0120_abs_001_w2aab3b7c14b1b6b1aab1c14b1Aa\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Perception of cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and pressurized intraperitoneal aerosol chemotherapy (PIPAC) for treating peritoneal surface malignancies (PSM) differ widely among physicians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2020-0120_abs_002_w2aab3b7c14b1b6b1aab1c14b2Aa\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This on-site survey performed during a major oncology congress in 2019 evaluated the current opinion, perceptions, knowledge and practice of HIPEC and PIPAC among oncologists in India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2020-0120_abs_003_w2aab3b7c14b1b6b1aab1c14b3Aa\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 147 respondents (gynecologists (30%), surgical oncologists and gastrointestinal surgeons (64%), and medical oncologists (6%)). Whereas most respondents considered CRS and HIPEC an appropriate therapeutic option, 25% would not recommend CRS and HIPEC. The main barriers to referral to an expert center were inaccessibility to such a center (37.8%), non-inclusion of CRS and HIPEC in clinical practice guidelines (32.4%), and a high morbidity\/mortality (21.6%). Variations were found in the various practice patterns of CRS\/HIPEC like eligibility criteria, HIPEC protocols and safety measures. Although PIPAC awareness as a novel therapeutic option was high, only a limited number of centers offered PIPAC, mainly because of non-access to technology and missing training opportunities (76.2%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2020-0120_abs_004_w2aab3b7c14b1b6b1aab1c14b4Aa\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Lack of widespread acceptance, poor accessibility and low utilization presents a significant challenge for HIPEC and PIPAC in India. There is a need to raise the awareness of curative and palliative therapeutic options for PSM. This might be achieved by the creation of expert centers, specialized training curricula and of a new sub-speciality in oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2020-0120","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T09:41:32Z","timestamp":1599471692000},"source":"Crossref","is-referenced-by-count":5,"title":["Practice patterns, attitudes, and knowledge among clinicians regarding hyperthermic intraperitoneal chemotherapy and pressurized intraperitoneal aerosol chemotherapy: a national survey by Indian society of peritoneal surface malignancies (ISPSM)"],"prefix":"10.1515","volume":"5","author":[{"given":"S. P.","family":"Somashekhar","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology , Manipal Comprehensive Cancer Center, Manipal Hospital , Bangalore , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumar C.","family":"Rohit","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , Manipal Comprehensive Cancer Center, Manipal Hospital , Bangalore , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. V. S.","family":"Deo","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences , New Delhi , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. R.","family":"Ashwin","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology , Manipal Comprehensive Cancer Center, Manipal Hospital , Bangalore , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"2025120909205925954_j_pp-2020-0120_ref_001_w2aab3b7c14b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Sadeghi, B, Arvieux, C, Glehen, O, Beaujard, AC, Rivoire, M, Baulieux, J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88: 358\u201363. https:\/\/doi.org\/10.1002\/(sici)1097-0142(20000115)88:2<358::aid-cncr16>3.0.co;2-o.","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O"},{"key":"2025120909205925954_j_pp-2020-0120_ref_002_w2aab3b7c14b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Jayne, DG, Fook, S, Loi, C, Seow-Choen, F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545\u201350. https:\/\/doi.org\/10.1046\/j.1365-2168.2002.02274.x.","DOI":"10.1046\/j.1365-2168.2002.02274.x"},{"key":"2025120909205925954_j_pp-2020-0120_ref_003_w2aab3b7c14b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Moreno, S., Gonz\u00e1lez-Bay\u00f3n, LA, Ortega-P\u00e9rez, G. Hyperthermic intraperitoneal chemotherapy: rationale and technique. World J Gastrointest Oncol 2010; 2: 68\u201375. https:\/\/doi.org\/10.4251\/wjgo.v2.i2.68.","DOI":"10.4251\/wjgo.v2.i2.68"},{"key":"2025120909205925954_j_pp-2020-0120_ref_004_w2aab3b7c14b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Chua, TC, Moran, BJ, Sugarbaker, PH, Levine, EA, Glehen, O, Gilly, FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012; 30: 2449\u201356. https:\/\/doi.org\/10.1200\/jco.2011.39.7166.","DOI":"10.1200\/jco.2012.30.4_suppl.532"},{"key":"2025120909205925954_j_pp-2020-0120_ref_005_w2aab3b7c14b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Elias, D, Lefevre, JH, Chevalier, J, Brouquet, A, Marchal, F, Classe, JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009; 27: 681\u20135. https:\/\/doi.org\/10.1200\/jco.2008.19.7160.","DOI":"10.1200\/JCO.2008.19.7160"},{"key":"2025120909205925954_j_pp-2020-0120_ref_006_w2aab3b7c14b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Verwaal, V, van Ruth, S, de Bree, E, van Slooten, G, van Tinteren, H, Boot, H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy vs. systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737\u201343. https:\/\/doi.org\/10.1200\/jco.2003.04.187.","DOI":"10.1200\/JCO.2003.04.187"},{"key":"2025120909205925954_j_pp-2020-0120_ref_007_w2aab3b7c14b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"van Driel, WJ, Koole, SN, Sikorska, K, Schagen van Leeuwen, JH, Schreuder, HW, Hermans, RH, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 2018; 378: 230\u201340. https:\/\/doi.org\/10.1056\/nejmoa1708618.","DOI":"10.1056\/NEJMoa1708618"},{"key":"2025120909205925954_j_pp-2020-0120_ref_008_w2aab3b7c14b1b6b1ab2b1b8Aa","unstructured":"Li, Y, Yu, Y, Liu, Y. Report on the 9th international congress on peritoneal surface malignancies. Cancer Biol Med 2014; 11: 281\u20134."},{"key":"2025120909205925954_j_pp-2020-0120_ref_009_w2aab3b7c14b1b6b1ab2b1b9Aa","unstructured":"Lehmann, K, H\u00fcbner, M. Pressurized intra-peritoneal aerosol chemotherapy (PIPAC): Ein n\u00e4chster Schritt in der chirurgischen Behand- lung der Peritonealkarzinomatose. Swiss Knife 2015; 1: 9\u201311."},{"key":"2025120909205925954_j_pp-2020-0120_ref_010_w2aab3b7c14b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Solass, W, Kerb, R, Murdter, T, Giger-Pabst, U, Strumberg, D, Tempfer, C, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 2014; 21: 553\u20139. https:\/\/doi.org\/10.1245\/s10434-013-3213-1.","DOI":"10.1245\/s10434-013-3213-1"},{"key":"2025120909205925954_j_pp-2020-0120_ref_011_w2aab3b7c14b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Reymond, MA, Solass, W. PIPAC: pressurized intraperitoneal aerosol chemotherapy: cancer under pressure. Berlin (Germany) Boston (Massachusetts): Walter de Gruyter GmbH; 2014.","DOI":"10.1515\/9783110366617"},{"key":"2025120909205925954_j_pp-2020-0120_ref_012_w2aab3b7c14b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Hubner, M, Grass, F, Teixeira-Farinha, H, Pache, B, Mathevet, P, Demartines, N. Pressurized intraperitoneal aerosol chemotherapy \u2013 practical aspects. Eur J Surg Oncol 2017; 43: 1102\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2017.03.019.","DOI":"10.1016\/j.ejso.2017.03.019"},{"key":"2025120909205925954_j_pp-2020-0120_ref_013_w2aab3b7c14b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Braam, HJ, Boerma, D, Wiezer, MJ, van Ramshorst, B. Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists. Int J Clin Oncol 2015; 20: 928\u201334. https:\/\/doi.org\/10.1007\/s10147-015-0816-5.","DOI":"10.1007\/s10147-015-0816-5"},{"key":"2025120909205925954_j_pp-2020-0120_ref_014_w2aab3b7c14b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Tabrizian, P, Overbey, J, Carrasco-Avino, G, Bagiella, E, Labow, DM, Sarpel, U. Escalation of socioeconomic disparities among patients with colorectal cancer receiving advanced surgical treatment. Ann Surg Oncol 2015; 22: 1746\u201350. https:\/\/doi.org\/10.1245\/s10434-014-4220-6.","DOI":"10.1245\/s10434-014-4220-6"},{"key":"2025120909205925954_j_pp-2020-0120_ref_015_w2aab3b7c14b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Cascales-Campos, P, Gil, J, Gil, E, Feliciangeli, E, Lopez, V, Gonzalez, AG, et al. Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma. Eur J Obstet Gynecol Reprod Biol 2011; 158: 361\u20132. https:\/\/doi.org\/10.1016\/j.ejogrb.2011.04.036.","DOI":"10.1016\/j.ejogrb.2011.04.036"},{"key":"2025120909205925954_j_pp-2020-0120_ref_016_w2aab3b7c14b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Bernaiche, T, Emery, E, Bijelic, L. Practice patterns, attitudes, and knowledge among physicians regarding cytoreductive surgery and HIPEC for patients with peritoneal metastases. Pleura Peritoneum 2018; 3: 1\u20137. https:\/\/doi.org\/10.1515\/pp-2017-0025.","DOI":"10.1515\/pp-2017-0025"},{"key":"2025120909205925954_j_pp-2020-0120_ref_017_w2aab3b7c14b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Yoo, HJ, Hong, JJ, Ko, YB, Lee, M, Kim, Y, Han, HY, et al. Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons. World J Surg Oncol 2018; 16: 92. Published 15 May 2018. https:\/\/doi.org\/10.1186\/s12957-018-1377-7.","DOI":"10.1186\/s12957-018-1377-7"},{"key":"2025120909205925954_j_pp-2020-0120_ref_018_w2aab3b7c14b1b6b1ab2b1c18Aa","unstructured":"Rajeev, R, Klooster, B, Turaga, KK. Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion. J Gastrointest Oncol 2016; 7: 122\u20138."},{"key":"2025120909205925954_j_pp-2020-0120_ref_019_w2aab3b7c14b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"van Gijn, W, Gooiker, GA, Wouters, MW, Post, PN, Tollenaar, RA, van de Velde, CJ. Volume and outcome in colorectal cancer surgery. Eur J Surg Oncol 2010; 36: S55\u201363. https:\/\/doi.org\/10.1016\/j.ejso.2010.06.027.","DOI":"10.1016\/j.ejso.2010.06.027"},{"key":"2025120909205925954_j_pp-2020-0120_ref_020_w2aab3b7c14b1b6b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Polanco, PM, Ding, Y, Knox, JM, Ramalingam, L, Jones, H, Hogg, ME, et al. Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies. Ann Surg Oncol 2015; 22: 1673\u20139. https:\/\/doi.org\/10.1245\/s10434-014-4111-x.","DOI":"10.1245\/s10434-014-4111-x"},{"key":"2025120909205925954_j_pp-2020-0120_ref_021_w2aab3b7c14b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Passot, G, Vaudoyer, D, Villeneuve, L, Kepenekian, V, Beaujard, AC, Bakrin, N, et al. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures: a 25-year wxperience of 1,125 HIPEC. J Surg Oncol 2016; 113: 796\u2013803. https:\/\/doi.org\/10.1002\/jso.24248.","DOI":"10.1002\/jso.24248"},{"key":"2025120909205925954_j_pp-2020-0120_ref_022_w2aab3b7c14b1b6b1ab2b1c22Aa","unstructured":"Dehal, A, Smith, JJ, Nash, GM. Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future. J Gastrointest Oncol 2016; 7: 143\u201357."},{"key":"2025120909205925954_j_pp-2020-0120_ref_023_w2aab3b7c14b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Grass, F, Martin, D, Montemurro, M, Mathevet, P, Wolfer, A, Coukos, G, et al. Current opinion and knowledge on peritoneal carcinomatosis: a survey among a Swiss oncology network. Chemotherapy 2018; 63: 143\u20137. https:\/\/doi.org\/10.1159\/000488774.","DOI":"10.1159\/000488774"},{"key":"2025120909205925954_j_pp-2020-0120_ref_024_w2aab3b7c14b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Narasimhan, V, Warrier, S, Michael, M, McCormick, J, Ramsay, R, Lynch, C, et al. Perceptions in the management of colorectal peritoneal metastases: a bi-national survey of colorectal surgeons. Pleura Peritoneum 2019; 4: 20190022. Published 30 Oct 2019. https:\/\/doi.org\/10.1515\/pp-2019-0022.","DOI":"10.1515\/pp-2019-0022"},{"key":"2025120909205925954_j_pp-2020-0120_ref_025_w2aab3b7c14b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Turaga, K, Levine, E, Barone, R, Sticca, R, Petrelli, N, Lambert, L, et al. Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol 2014; 21: 1501\u20135. https:\/\/doi.org\/10.1245\/s10434-013-3061-z.","DOI":"10.1245\/s10434-013-3061-z"},{"key":"2025120909205925954_j_pp-2020-0120_ref_026_w2aab3b7c14b1b6b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"Esquivel, J, Elias, D, Baratti, D, Kusamura, S, Deraco, M. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 2008; 98: 263\u20137. https:\/\/doi.org\/10.1002\/jso.21053.","DOI":"10.1002\/jso.21053"},{"key":"2025120909205925954_j_pp-2020-0120_ref_027_w2aab3b7c14b1b6b1ab2b1c27Aa","doi-asserted-by":"crossref","unstructured":"Somashekhar, SP, Ashwin, KR, Kumar, R, Naidu, N, Ramya, Y, Zaveri, SS, et al. Standardization of patient selection and hyperthermic intraperitoneal chemotherapy protocol for peritoneal surface malignancy in Indian patients. Indian J Gynecol Oncol 2017; 15: 55\u201363. https:\/\/doi.org\/10.1007\/s40944-017-0154-9.","DOI":"10.1007\/s40944-017-0154-9"},{"key":"2025120909205925954_j_pp-2020-0120_ref_028_w2aab3b7c14b1b6b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"Kuijpers, AM, Aalbers, AG, Nienhuijs, SW, de Hingh, IH, Wiezer, MJ, van Ramshorst, B, et al. Implementation of a standardized HIPEC protocol improves outcome for peritoneal malignancy. World J Surg 2015; 39: 453\u201360. https:\/\/doi.org\/10.1007\/s00268-014-2801-y.","DOI":"10.1007\/s00268-014-2801-y"},{"key":"2025120909205925954_j_pp-2020-0120_ref_029_w2aab3b7c14b1b6b1ab2b1c29Aa","doi-asserted-by":"crossref","unstructured":"Maciver, AH, Al-Sukhni, E, Esquivel, J, Skitzki, JJ, Kane, JM3rd, Francescutti, VA. Current delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS\/HIPEC) and perioperative practices: an international survey of high-volume surgeons. Ann Surg Oncol 2017; 24: 923\u201330. https:\/\/doi.org\/10.1245\/s10434-016-5692-3.","DOI":"10.1245\/s10434-016-5692-3"},{"key":"2025120909205925954_j_pp-2020-0120_ref_030_w2aab3b7c14b1b6b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"Bristow, RE, Zahurak, ML, Diaz-Montes, TP, Giuntoli, RL, Armstrong, DK. Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes. Gynecol Oncol 2009; 115: 334\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2009.08.025.","DOI":"10.1016\/j.ygyno.2009.08.025"},{"key":"2025120909205925954_j_pp-2020-0120_ref_031_w2aab3b7c14b1b6b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"Bristow, RE, Puri, I, Diaz-Montes, TP, Giuntoli, RL, Armstrong, DK. Analysis of contemporary trends in access to high-volume ovarian cancer surgical care. Ann Surg Oncol 2009; 16: 3422\u201330. https:\/\/doi.org\/10.1245\/s10434-009-0680-5.","DOI":"10.1245\/s10434-009-0680-5"},{"key":"2025120909205925954_j_pp-2020-0120_ref_032_w2aab3b7c14b1b6b1ab2b1c32Aa","doi-asserted-by":"crossref","unstructured":"Raspe, C, Flother, L, Schneider, R, Bucher, M, Piso, P. Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. Eur J Surg Oncol 2017; 43: 1013\u201327. https:\/\/doi.org\/10.1016\/j.ejso.2016.09.008.","DOI":"10.1016\/j.ejso.2016.09.008"},{"key":"2025120909205925954_j_pp-2020-0120_ref_033_w2aab3b7c14b1b6b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"Passot, G, Vaudoyer, D, Villeneuve, L, Wallet, F, Beaujard, AC, Boschetti, G, et al. A perioperative clinical pathway can dramatically reduce failure-to-rescue rates after cytoreductive surgery for peritoneal carcinomatosis: a retrospective study of 666 consecutive cytoreductions. Ann Surg 2017; 265: 806\u201313. https:\/\/doi.org\/10.1097\/sla.0000000000001723.","DOI":"10.1097\/SLA.0000000000001723"},{"key":"2025120909205925954_j_pp-2020-0120_ref_034_w2aab3b7c14b1b6b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"Maciver, AH, Al-Sukhni, E, Esquivel, J, Skitzki, JJ, Kane, JM, Francescutti, VA, et al. Current delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS\/HIPEC) and perioperative practices: an international survey of high-volume surgeons. Ann Surg Oncol 2017; 24: 923\u201330. https:\/\/doi.org\/10.1245\/s10434-016-5692-3.","DOI":"10.1245\/s10434-016-5692-3"},{"key":"2025120909205925954_j_pp-2020-0120_ref_035_w2aab3b7c14b1b6b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"Ortega-Deballon, P, Facy, O, Jambet, S, Magnin, G, Cotte, E, Beltramo, JL, et al. Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol 2010; 17: 1957\u201363. https:\/\/doi.org\/10.1245\/s10434-010-0937-z.","DOI":"10.1245\/s10434-010-0937-z"},{"key":"2025120909205925954_j_pp-2020-0120_ref_036_w2aab3b7c14b1b6b1ab2b1c36Aa","doi-asserted-by":"crossref","unstructured":"Kyriazanos, I, Kalles, V, Stefanopoulos, A, Spiliotis, J, Mohamed, F. Operating personnel safety during the administration of hyperthermic intraperitoneal chemotherapy (HIPEC). Surg Oncol 2016; 25: 308\u201314. https:\/\/doi.org\/10.1016\/j.suronc.2016.06.001.","DOI":"10.1016\/j.suronc.2016.06.001"},{"key":"2025120909205925954_j_pp-2020-0120_ref_037_w2aab3b7c14b1b6b1ab2b1c37Aa","doi-asserted-by":"crossref","unstructured":"Villa, AF, El Balkhi, S, Aboura, R, Sageot, H, Hasni-Pichard, H, Pocard, M, et al. Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC). In Health 2015; 53: 28\u201337. https:\/\/doi.org\/10.2486\/indhealth.2014-0025.","DOI":"10.2486\/indhealth.2014-0025"},{"key":"2025120909205925954_j_pp-2020-0120_ref_038_w2aab3b7c14b1b6b1ab2b1c38Aa","doi-asserted-by":"crossref","unstructured":"Strohlein, MA, Heiss, MM, Jauch, KW. The current status of immunotherapy in peritoneal carcinomatosis. Expert Rev Anticancer Ther 2016; 16: 1019\u201327. https:\/\/doi.org\/10.1080\/14737140.2016.1224666.","DOI":"10.1080\/14737140.2016.1224666"},{"key":"2025120909205925954_j_pp-2020-0120_ref_039_w2aab3b7c14b1b6b1ab2b1c39Aa","doi-asserted-by":"crossref","unstructured":"Grass, F, Vuagniaux, A, Teixeira-Farinha, H, Lehmann, K, Demartines, N, H\u00fcbner, M. Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg 2017; 104: 669\u201378. https:\/\/doi.org\/10.1002\/bjs.10521.","DOI":"10.1002\/bjs.10521"},{"key":"2025120909205925954_j_pp-2020-0120_ref_040_w2aab3b7c14b1b6b1ab2b1c40Aa","doi-asserted-by":"crossref","unstructured":"Morano, WF, Khalili, M, Chi, DS, Bowne, WB, Esquivel, J. Clinical studies in CRS and HIPEC: trials, tribulations, and future directions-a systematic review. J Surg Oncol 2018; 117: 245\u201359. https:\/\/doi.org\/10.1002\/jso.24813.","DOI":"10.1002\/jso.24813"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/5\/3\/article-20200120.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2020-0120\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2020-0120\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T10:38:47Z","timestamp":1765276727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2020-0120\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,8,25]]},"published-print":{"date-parts":[[2020,9,4]]}},"alternative-id":["10.1515\/pp-2020-0120"],"URL":"https:\/\/doi.org\/10.1515\/pp-2020-0120","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"type":"electronic","value":"2364-768X"},{"type":"print","value":"2364-7671"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"article-number":"20200120"}}